Article

Identification of potential inhibitors of SARS-CoV-2 S protein–ACE2 interaction by in silico drug repurposing

2021-11-11

Abstract excerpt

<h4>Background: </h4> Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new coronavirus discovered that appeared in Wuhan, China, in December 2019, causes COVID-19 disease which have resulted in cases similar to SARS-atypical pneumonia. Worldwide, around 116 million cases and 2.57 million deaths are reported with new cases and increasing mortality every day. To date, there is no specific commercial t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 89d38f07-cd6c-5ec2-be39-f2307c35b6e9
DOI: 10.12688/f1000research.52168.2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification of potential inhibitors of SARS-CoV-2 S protein–ACE2 interaction by in silico drug repurposingDOI 10.12688/f1000research.52168.2Read

Drug Repurposing for Covid-19: Discovery of Potential Small-Molecule Inhibitors of Spike Protein-ACE2 Receptor Interaction Through Virtual Screening and Consensus ScoringSemantic proximity Read

A Comprehensive SARS-CoV-2 Genomic Analysis Identifies Potential Targets for Drug RepurposingSemantic proximity Read

In silico screening of known small molecules to bind ACE2 specific RBD on Spike glycoprotein of SARS-CoV-2 for repurposing against COVID-19Semantic proximity Read

An Integrative in Silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS-CoV-2 Main ProteaseSemantic proximity Read

Interaction of Drug Candidates with Various SARS-CoV‑2 Receptors: An in Silico Study to Combat COVID-19Semantic proximity Read

Docking of Velpatasvir to the SARS-CoV-2 Viral Spike Protein-Human ACE2 Complex: repurposing for COVID-19Semantic proximity Read

Virtual screening FDA approved drugs against multiple targets of SARS‐CoV‐2Semantic proximity Read

Identification of drugs targeting multiple viral and human proteins using computational analysis for repurposing against COVID-19Semantic proximity Read

A protein interaction map identifies existing drugs targeting SARS-CoV-2Semantic proximity Read

A Comprehensive Review of Drug Repurposing Strategies against Known Drug Targets of COVID-19Semantic proximity Read

Phylogenetic analysis and In silico Screening of drug targets for ACE2 in Human and Spike Glycoprotein in Sars-CoV-2 for control of COVID19Semantic proximity Read

Identification of Drugs Targeting Multiple Viral and Human Proteins Using Computational Analysis for Repurposing Against COVID-19Semantic proximity Read